The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Jardiance (empagliflozin) for the treatment of adults with chronic kidney disease (CKD), Boehringer Ingelheim and Eli Lilly and Company announced.
Regulatory authorities have been focusing on safeguarding global supply chains. Juan Torrijos Lopez, GMP consultant at Rephine provides some practical pointers as to how pharmaceutical manufacturers should respond to evolving expectations.
Responsible Manufacturing Can Help Curb Drug Resistance: New report sets out clear steps pharmaceutical companies should take to limit AMR risk in antibiotic production.
Tim Lin, Director of the Technical Services Department, Bora, discusses the benefits of utilising Wurster coating technology, laying out steps to overcome challenges and optimise controlled-release profiles for efficient and effective drug delivery.
Prashant Deshpande, Head, Process & Technology Support at ACG Engineering, discusses the critical process parameters of film coating and the measurement, monitoring and recording of tablet bed temperature in batch manufacturing.
Ascendis Pharma and Phillips-Medisize Receive Third Award for the SKYTROFA Auto-Injector. his first-of-its-kind product enables convenient and efficient preparation and delivery of SKYTROFA—a vital growth hormone treatment for children.
Rex Clements, CEO at Centrient Pharmaceuticals, sheds light on the company’s efforts to contribute to a more sustainable global supply chain for antibiotics.
Clinical trials are pivotal in advancing medical research and developing cutting-edge treatments. They serve as a vital bridge between scientific innovation and patient care, allowing for evaluating new therapies, medicines, and medical devices.
Dr. Peter Hamley, Chief Scientific Officer at Samsara Therapeutics, explores whether developments in therapeutics for neurodegenerative diseases are truly disease modifying or addressing the symptoms of a deeper problem.
